A randomized crossover study comparing the antiplatelet effect of plavix versus generic clopidogrel
A randomized crossover study comparing the antiplatelet effect of plavix versus generic clopidogrel
Background: Clopidogrel exists in different salt formulations. All published data that have demonstrated its beneficial effect are based entirely on the hydrogen sulphate salt contained in the branded product Plavix, which had US sales of $6.1 billion in 2010 alone. A number of cheaper generic versions of clopidogrel are increasingly being used in Europe as an alternative to Plavix, mainly for cost reasons. However, there is insufficient evidence to show that their pharmacodynamic effect is equivalent to Plavix.
Methods: This prospective study investigated whether there is any significant difference in the antiplatelet effect of Plavix versus generic clopidogrel hydrochloride in healthy male volunteers. All participants received loading and maintenance doses of both drugs, in a crossover manner, separated by a 2-week washout period. Adenosine diphosphate (ADP)-induced platelet reactivity was measured using short thrombelastography at multiple timepoints.
Results: The results showed interindividual heterogeneity in responses to clopidogrel but no significant difference in ADP-induced platelet reactivity between Plavix versus generic clopidogrel hydrochloride.
Conclusions: Our findings suggest comparable inhibition of ADP-induced platelet reactivity with Plavix and generic clopidogrel hydrochloride. This observation is particularly pertinent at a time when the patent for Plavix is expected to expire in the near future leading to the large-scale switch to cheaper generic preparations.
antiplatelet therapy, clopidogrel, platelet aggregation
495-501
Sambu, Nalyaka
7d0ba3fb-e39e-48d7-a0e4-ce249acc5980
Radhakrishnan, A.
3db27dff-d225-46da-97c5-c85cec618735
Curzen, N.
70f3ea49-51b1-418f-8e56-8210aef1abf4
December 2012
Sambu, Nalyaka
7d0ba3fb-e39e-48d7-a0e4-ce249acc5980
Radhakrishnan, A.
3db27dff-d225-46da-97c5-c85cec618735
Curzen, N.
70f3ea49-51b1-418f-8e56-8210aef1abf4
Sambu, Nalyaka, Radhakrishnan, A. and Curzen, N.
(2012)
A randomized crossover study comparing the antiplatelet effect of plavix versus generic clopidogrel.
Journal of Cardiovascular Pharmacology, 60 (6), .
(doi:10.1097/FJC.0b013e31826f36bc).
(PMID:23232787)
Abstract
Background: Clopidogrel exists in different salt formulations. All published data that have demonstrated its beneficial effect are based entirely on the hydrogen sulphate salt contained in the branded product Plavix, which had US sales of $6.1 billion in 2010 alone. A number of cheaper generic versions of clopidogrel are increasingly being used in Europe as an alternative to Plavix, mainly for cost reasons. However, there is insufficient evidence to show that their pharmacodynamic effect is equivalent to Plavix.
Methods: This prospective study investigated whether there is any significant difference in the antiplatelet effect of Plavix versus generic clopidogrel hydrochloride in healthy male volunteers. All participants received loading and maintenance doses of both drugs, in a crossover manner, separated by a 2-week washout period. Adenosine diphosphate (ADP)-induced platelet reactivity was measured using short thrombelastography at multiple timepoints.
Results: The results showed interindividual heterogeneity in responses to clopidogrel but no significant difference in ADP-induced platelet reactivity between Plavix versus generic clopidogrel hydrochloride.
Conclusions: Our findings suggest comparable inhibition of ADP-induced platelet reactivity with Plavix and generic clopidogrel hydrochloride. This observation is particularly pertinent at a time when the patent for Plavix is expected to expire in the near future leading to the large-scale switch to cheaper generic preparations.
This record has no associated files available for download.
More information
Published date: December 2012
Keywords:
antiplatelet therapy, clopidogrel, platelet aggregation
Organisations:
Human Development & Health
Identifiers
Local EPrints ID: 355250
URI: http://eprints.soton.ac.uk/id/eprint/355250
ISSN: 0160-2446
PURE UUID: 085cae0d-8569-4f30-a1f2-2c2cf772e6d9
Catalogue record
Date deposited: 19 Aug 2013 12:53
Last modified: 15 Mar 2024 03:23
Export record
Altmetrics
Contributors
Author:
Nalyaka Sambu
Author:
A. Radhakrishnan
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics